Skip to content

Avitene 1010080

by Davol Inc.

Avitene 1010080 is a Class III device made by Davol Inc., approved under FDA PMA P800002 on 28 Jan 1982 and listed in FDA GUDID since 12 Sep 2014 (UDI-DI 00801741010453), active as of 23 Oct 2026.

Active United States. Also listed in GUDID (US).

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 23 Oct 2026

Documents

PMA P800002

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00801741010453 UDI-DI Date12 Sep 2014ListedStatusListed GUDID: in commercial distribution
United StatesFDA PMAAPPR from GUDID Approved NumberP800002 Date28 Jan 1982DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA PMA P800002 decided 28 Jan 1982 Active
  • FDA GUDID UDI-DI 00801741010453 listed 12 Sep 2014 Listed

Timeline

2 dated events

  1. Approved FDA PMA P800002
  2. Listed FDA GUDID 00801741010453

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

GUDID

Trade name
Avitene
Generic name
Collagen haemostatic agent, non-antimicrobial
Model / Ref / Catalog
1010080
Primary DI / UDI-DI
00801741010453
PMA number
FDA product code
LMF
GMDN term
Collagen haemostatic agent, non-antimicrobial
Device class
Class III
Regulation number
878.4490
GUDID distribution status
In Commercial Distribution
Size
Length — 35 Millimeter
Width — 35 Millimeter
Depth — 1 Millimeter

Similar devices

Other devices filed under FDA product code LMF (Agent, absorbable hemostatic, collagen based).

Other devices from Davol Inc.

See all devices from Davol Inc. →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (8, all answered No)